Target intelligence / Profile preview

Salmonella Enteritidis O-antigen

Molecular classification
Other (Surface glycan, bacterial polysaccharide antigen), Virulence factor
01

Overview

The **Salmonella Enteritidis O-antigen** is a structurally variable, surface-exposed polysaccharide forming the distal part of lipopolysaccharide (LPS) molecules in the outer membrane of *Salmonella enterica* serovar Enteritidis[1][2][3][5]. It consists of repeated oligosaccharide units (the chemical structure can include sugars like mannose, rhamnose, galactose, with serovar-defining side chains and decorations[3][5]). The O-antigen is a key antigenic determinant used in serotyping and a major virulence factor that enables Salmonella to evade host immune responses, resist serum complement, and persist in infection[1][2][5]. Its biosynthesis is genetically encoded (typically on the Salmonella chromosome, e.g., at the rfb locus), involving pathways like Wzx/Wzy-dependent synthesis and additional modifications by various enzymes[1][3][5]. The O-antigen serves as a primary target for the host immune system—antibody responses against it are protective, making it a principal component in the development of vaccines (including conjugate/glycoengineered vaccines and GMMA-based OMV vaccines)[5].

Other names
O-antigen (of Salmonella Enteritidis)O-polysaccharideOPSO-specific polysaccharideLPS O-antigen (in the context of lipopolysaccharide)
02

Mechanism of action

Antibody targeting: Antibodies bind O-antigen, leading to complement-mediated killing or opsonization[2][5] Vaccine-induced immunity: Induced generation of protective antibodies against exposed O-antigen[5]

03

Biological functions

Immune evasion (interferes with host immune recognition)Virulence (facilitates systemic dissemination)Antigenic determinant (used for serotype specificity)Structural component of bacterial outer membrane
04

Disease associations

Infection (especially invasive Salmonella infections)Immune evasion in host-pathogen interactions
05

Safety considerations

Potential for antigenic diversity and variation, contributing to immune escape[3][5]Polysaccharide antigens typically induce weaker, T-cell-independent immune responses in infants and young children, limiting the effectiveness of simple polysaccharide vaccines[5]Potential cross-reactivity with structurally similar O-antigens from other Enterobacteriaceae[3][5]
06

Interacting drugs

No approved small-molecule drugs; target for vaccines (e.g., GMMA-based vaccines[*][5])

2 more in the full profile.

07

Biomarkers

Serovar-specific anti-O-antigen antibodies (serological classification and diagnostic marker)O-antigen detection in blood culture or direct agglutination[2][5]

Beyond the preview

Go deeper on Salmonella Enteritidis O-antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Enteritidis O-antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call